Cargando…
The Place and Prognostic Value of TERT Promoter Mutation in Molecular Classification in Grade II-III Glial Tumors and Primary Glioblastomas
Objective: Diffuse gliomas, the most common primary malignant brain tumors, have been classified by the World Health Organization as class II-IV gliomas. After 2016, two mutations in the promoter region of the telomerase reverse transcriptase (TERT) gene were identified in addition to the IDH, 1p /...
Autores principales: | Kaya Terzi, Neslihan, Yılmaz, İsmail, Oz, Aysim Buge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Federation of Turkish Pathology Societies
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999695/ https://www.ncbi.nlm.nih.gov/pubmed/34558656 http://dx.doi.org/10.5146/tjpath.2021.01555 |
Ejemplares similares
-
The Applicability of Haarlem Integrated Diagnostic System in Diffuse Glial Tumors and Molecular Methods Affecting Prognosis
por: Kaya Terzi, Neslihan, et al.
Publicado: (2019) -
Is it possible to predict atherosclerosis in the ascending aorta by the patient’s lipid panel?
por: Haberal, İsmail, et al.
Publicado: (2020) -
TERT promoter mutations in primary and secondary WHO grade III meningioma
por: Maier, Andrea Daniela, et al.
Publicado: (2020) -
Comparison of Different ROS1 Immunohistochemistry Clones and Consistency with Fluorescence In Situ Hybridization Results in Non-Small Cell Lung Carcinoma
por: Dülger, Onur, et al.
Publicado: (2023) -
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
por: Mosrati, Mohamed Ali, et al.
Publicado: (2015)